Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications.
In this weeks issue of Eurosurveillance, Zambon and colleagues describe the first findings of the European Union-funded European Surveillance Network for Vigilance Against Viral Resistance (VIRGIL) of some seasonal influenza viral isolates resistant to the antiviral drug oseltamivir in Europe.
Nicoll
A
A
Ciancio
B
B
Kramarz
P
P
D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral; D005060:Europe; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000472:pathogenicity; D007251:Influenza, Human / Q000188:drug therapy / Q000401:mortality / Q000821:virology; D053139:Oseltamivir / Q000494:pharmacology*; D012621:Seasons; D014774:Virulence; D014944:World Health Organization
D000998:Antiviral Agents; D053139:Oseltamivir